|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
A&D Pharma Bulgaria (Ей енд Ди Фарма България)
Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name A&D Pharma Bulgaria EAD (Ей енд Ди Фарма България ЕАД) Previous name(s) Arishop Pharma (2010) Headquarters 49B, Bulgaria Blvd, Fl. 4; Sofia; Sofia - city; 1404 |
Status: Non-Listed Legal Form: Joint Stock Company Operational Status: Operational BG VAT Identification Code: BG131107072 BULSTAT: 131107072 Incorporation Date: June 25, 2003 Total Employees: 213 Tel: (+359 2) 810 39 49, 810 39 59 |
|
Company Description |
| A&D Pharma Bulgaria was established in 2003 under the Ariplus name. The company is primarily engaged in wholesaling pharmaceuticals. In 2010 Netherlands-based Greenville BV sold its 100% stake in the firm to A&D Pharma Holdings. |
Company Analysis |
| According to the Consolidated - Audited financial statement for the Year of 2011, total net operating revenues decreased with -3.81%, from BGN 72,919 thousands to BGN 70,144 thousands. Operating result increased from BGN 2,351 thousands to BGN 5,697 thousands which means 142.32% change. The results of the period increased 219.40% reaching BGN 4,906 thousands at the end of the period against BGN 1,536 thousands last year. Return on equity (Net income/Total equity) went from 14.21% to 55.46%, the Return On Asset (Net income / Total Asset) went from 4.09% to 14.13% and the Net Profit Margin (Net Income/Net Sales) went from 2.11% to 6.99% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 292.44% compared to 247.66% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.08 to 1.27 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2011 Y (cons) |
2010 Y (cons) |
|
 | ||
| Audited | Audited | |
| ||
| ISI Financial Statements | ISI Financial Statements | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
34,715 |
37,593 |
| ||
Current Assets |
XX,XXX |
XX,XXX |
| ||
Total Liabilities |
XX,XXX |
XX,XXX |
| ||
Shareholders Equity |
X,XXX |
XX,XXX |
| ||
Current Liabilities |
XX,XXX |
XX,XXX |
| ||
| * All the accounts are in BGN. | ||
Income Statement
| ||
Total Operating Revenue |
XX,XXX |
XX,XXX |
| ||
Operational Profit (Loss) |
X,XXX |
X,XXX |
| ||
Net Profit (Loss) |
X,XXX |
X,XXX |
| ||
| * All the accounts are in BGN. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
XX.XX% |
X.XX% |
| ||
Annualised Return on Assets (ROA) |
XX.XX% |
X.XX% |
| ||
Return on Equity (ROE) |
XX.XX% |
XX.XX% |
| ||
Annualised Return on Equity (ROE) |
XX.XX% |
XX.XX% |
| ||
Return on Sales (ROS) |
X.XX% |
X.XX% |
| ||
Return on Capital |
XX.XX% |
XX.XX% |
| ||
Gross Profit Margin |
XX.XX% |
XX.XX% |
| ||
Operating Profit Margin |
X.XX% |
X.XX% |
| Efficiency Ratios | ||
| ||
Inventory Turnover |
X.XXx |
X.XXx |
| ||
Current asset turnover |
X.XXx |
X.XXx |
| ||
Fixed-asset turnover |
XX.XXx |
X.XXx |
| ||
Asset Turnover |
X.XXx |
X.XXx |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
X,XXX |
X,XXX |
| ||
EBITDA |
X,XXX |
X,XXX |
| ||
Bookvalue (BV) |
X,XXX |
XX,XXX |
| ||
Net Cash |
-XX,XXX |
-XX,XXX |
| Liquidity Ratios | ||
| ||
Current Ratio |
XXX.XX% |
XXX.XX% |
| ||
Quick ratio |
XX.XX% |
XX.XX% |
| ||
Doom's day ratio |
X.XX% |
X.XX% |
| Leverage Ratios | ||
| ||
Leverage ratio |
XXX.XX% |
XXX.XX% |
| ||
Debt to equity |
XXX.XX% |
XXX.XX% |
| ||
Debt to total assets |
XX.XX% |
XX.XX% |
| ||
Long Term Debt to Capital |
X.XX% |
X.XX% |
| Trend Ratios | ||
| ||
Revenue Trend |
XX.XX% |
XXX.XX% |
| ||
Net Income Trend |
XXX.X% |
XX.XX% |
| ||
Operating Income Trend |
XXX.XX% |
XX.XX% |
| ||
 |